Abstract
A 61-year-old Japanese woman was diagnosed with FIGO Stage IB endometrioid cancer (EC) combined with large cell neuroendocrine carcinoma (LCNEC). Metastasis to the lymph nodes in the right bronchopulmonary area, mediastinum and brain were also identified. The patient eventually developed pleuritis and pericarditis carcinomatosa, and died of cancer at 51 months after surgery. Because gene aberrations in uterine neuroendocrine carcinoma are still not well understood, we examined alterations in the mutational hotspots of 50 selected cancer-associated genes. The EC and LCNEC components shared identical alterations in PTEN, PIK3CA and FGFR3. Both the EC and LCNEC components had heterozygous SBSs on CTNNB1 but at different codons (G34R in EC, and T41A in LCNEC). The altered gene signature raised a possibility that the EC and LCNEC components were derived from a common precursor lesion. The LCNEC independently obtained a significant CTNNB1 mutation and the lymph node metastasis originated from this component. Because the LCNEC component seemed to bring about the aggressive course of the disease and defined the patient outcome, further investigations are needed to elucidate the mechanism of NE carcinoma development in the endometrium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jones MH, Virtanen C, Honjoh D et al (2004) Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 363:775–781
Hiroshima K, Iyoda A, Shida T et al (2006) Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol 19:1358–1368
Nitadori J, Ishii G, Tsuta K et al (2006) Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. Am J Clin Pathol 125:682–692
Terada T (2010) Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol Res Pract 206:420–425
Erhan Y, Dikmen Y, Yucebilgin MS et al (2004) Large cell neuroendocrine carcinoma of the uterine corpus metastatic to brain and lung: case report and review of the literature. Eur J Gynaecol Oncol 25:109–112
Mulvany NJ, Allen DG (2007) Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol 27:49–57
Albores-Saavedra J, Martinez-Benitez B, Leuvano E (2008) Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol 27:333–339
Posligua L, Malpica A, Liu J et al (2008) Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread. Arch Pathol Lab Med 132:1821–1824
Deodhar KK, Kerkar RA, Suryawanshi P et al (2011) Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts. J Cancer Res Ther 7:211–213
Shahabi S, Pellicciotta I, Hou J et al (2011) Clinical utility of chromogranin A and octreotide in large cell neuroendocrine carcinoma of the uterine corpus. Rare Tumors 3(e41):129–131
Makihara N, Maeda T, Nishimura M et al (2012) Large cell neuroendocrine carcinoma originating from the uterine endometrium: a report on magnetic resonance features of 2 cases with very rare and aggressive tumor. Rare Tumors 4(e37):118–121
Nguyen MT, Han L, Minors AM et al (2013) Rare large cell neuroendocrine tumor of the endometrium: a case report and review of the literature. Int J Surg Case Rep 4:651–655
Rudd ML, Price JC, Fogoros S et al (2011) A unique spectrum of somatic PIK3CA (p110 alpha) mutation within primary endometrial carcinoma. Clin Cancer Res 17:1331–1340
McConechy MK, Ding J, Senz J et al (2014) Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol 27:128–134
Hong B, Le Gallo M, Bell DW et al (2015) The mutational landscape of endometrioid cancer. Curr Opin Genet Dev 30:25–31
Merritt MA, Dw Cramer et al (2010) Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark 9:287–305
George LM, Lin Ming-Chieh, Jeffrey T et al (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924–931
Rekhtman N, Pietanza MC, Hellmann MD et al (2016) Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets. Clin Res 22(14):3618–3629
Conflict of interest
All the authors state that they have no potential conflict of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Ariura, M., Kasajima, R., Miyagi, Y. et al. Combined large cell neuroendocrine carcinoma and endometrioid carcinoma of the endometrium: a shared gene mutation signature between the two histological components. Int Canc Conf J 6, 11–15 (2017). https://doi.org/10.1007/s13691-016-0263-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-016-0263-9